Table 12.
BPA and gonadotrophic hormones (epidemiological studies)
| Study design | Study population | Sample size | Time of BPA measurement | BPA concentration | Outcome | Ref |
|---|---|---|---|---|---|---|
| Retrospective | Women exposed to BPA in workplace | 106 exposed, 250 unexposed | Air sampling+ spot urine sample | Geometric (total BPA) mean (95% confidence interval) Exposed: 22.3 (12.4, 39.8 μg/g cr); unexposed: 0.9 (0.7, 1,1) |
Positive association between prolactin and urine BPA levels (all women); negative association between FSH and BPA (unexposed group) | (124) |
| Prospective | Women undergoing in vitro fertilization | Overall 209 (antral follicle count=154; FSH=120; ovarian volume= 114) | Urine: upon entry into the study and subsequent treatment visits; Ultrasound: 3rd day of an unstimulated menstrual cycle | Urinary geometric mean (geometric standard deviation); Antral follicle count= 1.6 (2.0); FSH= 1.7 (2.1); ovarian volume= 1.5 (1.8) | No association with day 3-FSH or ovarian volume; Higher urinary BPA concentrations associated with lower antral follicle counts | (85) |